Chemocentryx (CCXI) Shareholder P-A-W Capital Has Trimmed Its Stake as Share Value Rose; Weybosset Research & Management Trimmed Its Stake in Ingredion (INGR) as Stock Price Declined

ChemoCentryx, Inc. (NASDAQ:CCXI) Logo

P-A-W Capital Corp decreased its stake in Chemocentryx Inc (CCXI) by 44.44% based on its latest 2018Q4 regulatory filing with the SEC. P-A-W Capital Corp sold 40,000 shares as the company’s stock rose 6.99% with the market. The hedge fund held 50,000 shares of the health care company at the end of 2018Q4, valued at $546,000, down from 90,000 at the end of the previous reported quarter. P-A-W Capital Corp who had been investing in Chemocentryx Inc for a number of months, seems to be less bullish one the $713.49 million market cap company. The stock decreased 3.06% or $0.39 during the last trading session, reaching $12.36. About 124,186 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 12.22% since May 8, 2018 and is uptrending. It has outperformed by 7.85% the S&P500. Some Historical CCXI News: 31/03/2018 – ChemoCentryx Conference Set By H.C. Wainwright for Apr. 8-10; 09/03/2018 – ChemoCentryx Intends to Initiate Clinical Development of Avacopan in Hidradenitis Suppurativa by Yr-En; 13/03/2018 – CHEMOCENTRYX INC CCXI.O : JP MORGAN RAISES TARGET PRICE TO $16 FROM $13; 09/03/2018 – CHEMOCENTRYX SEES 2018 CASH & INVESTMENTS USE $65M-$75M; 23/05/2018 – ChemoCentryx Announces Two Upcoming Presentations at the 55th ERA-EDTA Congress; 10/05/2018 – Invus Public Equities Advisors Exits Position in ChemoCentryx; 09/03/2018 – ChemoCentryx Expects to Utilize Between $65M-$75M Cash and Investments in FY18; 09/03/2018 ChemoCentryx 4Q EPS 80c; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in the Treatment of Focal Segmental Glomerulosclerosis (FSGS); 11/04/2018 – ChemoCentryx Announces Presentation During National Kidney Foundation 2018 Spring Clinical Meeting

Weybosset Research & Management Llc decreased its stake in Ingredion Inc (INGR) by 12% based on its latest 2018Q4 regulatory filing with the SEC. Weybosset Research & Management Llc sold 9,290 shares as the company’s stock declined 12.58% while stock markets rallied. The institutional investor held 68,113 shares of the packaged foods company at the end of 2018Q4, valued at $6.23 million, down from 77,403 at the end of the previous reported quarter. Weybosset Research & Management Llc who had been investing in Ingredion Inc for a number of months, seems to be less bullish one the $5.60 billion market cap company. The stock decreased 1.73% or $1.48 during the last trading session, reaching $83.95. About 136,268 shares traded. Ingredion Incorporated (NYSE:INGR) has declined 28.89% since May 8, 2018 and is downtrending. It has underperformed by 33.26% the S&P500. Some Historical INGR News: 30/05/2018 – SweeGen and lngredion bring non-GMO Reb M to Colombia; 03/05/2018 – Ingredion Sees 2018 EPS $7.90-EPS $8.20; 20/04/2018 – INGREDION RAISED TO Baa1 FROM Baa2 BY MOODY’S; 03/05/2018 – INGREDION INC INGR.N SEES FY 2018 ADJUSTED SHR $7.90 TO $8.20; 03/05/2018 – Ingredion 1Q EPS $1.68; 20/04/2018 – Moody’s Expecs Ingredion Will Remain One of the Top Producers of Starches and Sweeteners; 04/04/2018 – Ingredion Closes Above 200-Day Moving Average: Technicals; 20/04/2018 – Moody’s Upgrades Ingredion To Baa1; Outlook Stable; 16/05/2018 – Ingredion Presenting at Bank of Montreal Conference Tomorrow; 20/04/2018 – Moody’s Upgrades lngredion to Baa1; Outlook Stable

Investors sentiment decreased to 0.93 in 2018 Q4. Its down 0.05, from 0.98 in 2018Q3. It dropped, as 7 investors sold CCXI shares while 38 reduced holdings. 18 funds opened positions while 24 raised stakes. 27.13 million shares or 1.23% more from 26.80 million shares in 2018Q3 were reported. Barclays Public Ltd accumulated 5,866 shares. Raymond James And Assocs invested in 12,174 shares. J Goldman And LP holds 0.04% or 45,500 shares in its portfolio. Aqr Mngmt Ltd Liability Corporation holds 22,364 shares or 0% of its portfolio. Citadel Advsrs Llc holds 19,773 shares. Fernwood Ltd Llc owns 10,000 shares. Ameriprise Inc reported 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Commercial Bank Of America Corp De invested in 93,623 shares or 0% of the stock. Daiwa Grp Inc accumulated 269 shares. Prelude Capital Llc invested in 0% or 1,076 shares. Adams Diversified Equity Fund has invested 0.03% in ChemoCentryx, Inc. (NASDAQ:CCXI). California Public Employees Retirement Sys has 0% invested in ChemoCentryx, Inc. (NASDAQ:CCXI) for 67,452 shares. Deutsche Bancorp Ag stated it has 84,345 shares. Moreover, Arrowstreet Cap Lp has 0.01% invested in ChemoCentryx, Inc. (NASDAQ:CCXI) for 220,004 shares. Tiaa Cref Inv Mngmt Ltd Com invested in 0% or 311,491 shares.

Analysts await ChemoCentryx, Inc. (NASDAQ:CCXI) to report earnings on August, 8. They expect $-0.26 earnings per share, down 85.71% or $0.12 from last year’s $-0.14 per share. After $-0.23 actual earnings per share reported by ChemoCentryx, Inc. for the previous quarter, Wall Street now forecasts 13.04% negative EPS growth.

More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Seekingalpha.com which released: “ChemoCentryx withdraws conditional approval application for avacopan in Europe – Seeking Alpha” on January 24, 2019, also Globenewswire.com with their article: “Report: Exploring Fundamental Drivers Behind Lincoln National, News Corporation, Macerich, ChemoCentryx, Delek Logistics Partners, and SunCoke Energy Partners — New Horizons, Emerging Trends, and Upcoming Developments – GlobeNewswire” published on April 16, 2019, Seekingalpha.com published: “ChemoCentryx terminates previously announced common stock offering – Seeking Alpha” on September 28, 2018. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Seekingalpha.com and their article: “ChemoCentryx (CCXI) CEO Thomas Schall on Q3 2018 Results – Earnings Call Transcript – Seeking Alpha” published on November 08, 2018 as well as Globenewswire.com‘s news article titled: “ChemoCentryx to Present at the 8th Annual SVB Leerink Global Healthcare Conference – GlobeNewswire” with publication date: February 20, 2019.

Since January 7, 2019, it had 0 buys, and 5 sales for $1.38 million activity. The insider Cappel Markus J. sold 13,203 shares worth $158,790. KANAYA SUSAN M sold $457,747 worth of stock.

P-A-W Capital Corp, which manages about $79.74M US Long portfolio, upped its stake in Usa Technologies Inc (NASDAQ:USAT) by 170,945 shares to 180,000 shares, valued at $700,000 in 2018Q4, according to the filing.

Weybosset Research & Management Llc, which manages about $189.62M and $146.51 million US Long portfolio, upped its stake in Tjx Cos Inc (NYSE:TJX) by 74,996 shares to 150,747 shares, valued at $6.74 million in 2018Q4, according to the filing.

Analysts await Ingredion Incorporated (NYSE:INGR) to report earnings on August, 1. They expect $1.70 EPS, up 2.41% or $0.04 from last year’s $1.66 per share. INGR’s profit will be $113.36M for 12.35 P/E if the $1.70 EPS becomes a reality. After $1.54 actual EPS reported by Ingredion Incorporated for the previous quarter, Wall Street now forecasts 10.39% EPS growth.

Investors sentiment decreased to 0.69 in Q4 2018. Its down 0.25, from 0.94 in 2018Q3. It dropped, as 36 investors sold INGR shares while 154 reduced holdings. 40 funds opened positions while 92 raised stakes. 61.46 million shares or 5.35% more from 58.34 million shares in 2018Q3 were reported. 98,091 are held by Citigroup. Charles Schwab has invested 0.05% in Ingredion Incorporated (NYSE:INGR). Alliancebernstein Ltd Partnership holds 794,254 shares. Corecommodity Ltd Limited Liability Company reported 26,039 shares. Signaturefd Ltd Llc has invested 0.01% in Ingredion Incorporated (NYSE:INGR). Hutchinson Cap Management Ca stated it has 1.86% in Ingredion Incorporated (NYSE:INGR). Gemmer Asset Mgmt Limited Liability, a California-based fund reported 105 shares. Morgan Stanley has invested 0.01% of its portfolio in Ingredion Incorporated (NYSE:INGR). Denali Advsr Limited Liability holds 0.87% or 56,900 shares in its portfolio. Jpmorgan Chase & Co stated it has 0% of its portfolio in Ingredion Incorporated (NYSE:INGR). Envestnet Asset Incorporated accumulated 0.01% or 39,179 shares. Employees Retirement Association Of Colorado holds 0.01% or 12,642 shares in its portfolio. 2,271 are owned by Mackenzie Financial. Enterprise Fincl Ser Corp reported 73 shares. Arizona State Retirement Sys reported 0.1% stake.

More notable recent Ingredion Incorporated (NYSE:INGR) news were published by: Streetinsider.com which released: “Form 8-K Ingredion Inc For: May 02 – StreetInsider.com” on May 02, 2019, also Seekingalpha.com with their article: “Ingredion Q1 2019 Earnings Preview – Ingredion Incorporated (NYSE:INGR) – Seeking Alpha” published on May 01, 2019, Seekingalpha.com published: “Ingredion, Inc. 2018 Q4 – Results – Earnings Call Slides – Seeking Alpha” on February 05, 2019. More interesting news about Ingredion Incorporated (NYSE:INGR) were released by: Globenewswire.com and their article: “INGREDION TO PRESENT AT BMO CAPITAL MARKETS 14TH ANNUAL FARM TO MARKET CONFERENCE IN NEW YORK – GlobeNewswire” published on April 29, 2019 as well as Globenewswire.com‘s news article titled: “INGREDION LEADS SERIES B FUNDING FOR CLARA FOODS AND CONTINUES EXPANDING ITS PROTEIN PORTFOLIO – GlobeNewswire” with publication date: April 25, 2019.

ChemoCentryx, Inc. (NASDAQ:CCXI) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *